Drug Pricing Program – Talk Bio

Actionable Insights Powered by AI

Hospital Group Seeks to Intervene in Lawsuit Against Lilly’s 340B Rebate Model

3 months ago talkbio0Tagged Drug Pricing Program, Eli, Eli Lilly, hospital intervention, Study models, United States Health Resources and Services Administration

340B Drug Pricing Program, Eli Lilly, rebate model, lawsuit, hospital intervention, Health Resources and Services Administration (HRSA), drug pricing

Eli Lilly and Johnson & Johnson Sue US Government Over 340B Rebate Models

5 months ago talkbio0Tagged Drug Pricing Program, Eli, Eli Lilly, healthcare litigation, HRSA, Johnson & Johnson, pharmaceutical pricing, rebate, Study models

340B Drug Pricing Program, Eli Lilly, Johnson & Johnson, HRSA, rebate models, pharmaceutical pricing, healthcare litigation